NCT06902753 · SUSPENDED

Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language

This study is building and standardizing a memory test in French Sign Language, based on a 16-word recall test used in memory assessment. Researchers will gather norms from deaf adults with no cognitive problems. It involves a questionnaire and exam, not a drug. There is no phase, because it tests an assessment tool, not a treatment.

Eligibility criteria

Inclusion Criteria:
* Person aged ≥ 18 yo
* with severe or profound deafness (hearing loss ≥ 70 decibels), early diagnosed (before 6 years old)
* whose main language is French Sign Language
* able to consent in writing after a clear explanation of the procedure
* affiliated to the French Healthcare system (Sécurité Sociale) through self or another person
Non-inclusion criteria:
* person with a medical history in neurology (stroke, traumatic brain injury, dementia) or psychiatry bipolar syndrom or schizophrenia that would not be medicated, severe depression)
* persons with medical developmental backgroung (e.g genetic syndrome)
* person with cancer history needing chemotherapy
* person with a diagnosed and untreated sleeping trouble
* person drinking > 10 glasses of alcohol per week or using drugs on a daily basis
* person with visual issues not corrected
Exclusion Criteria:
A score ≤ 20/28 or 17/28 at the MMS-LS test, depending on the schooling of the participant (20/28 for participants with a degree, 17/28 for participants without a degree)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-16

View full record on ClinicalTrials.gov

All APOE4 clinical trials